On 28th November OxTalks will move to the new Halo platform and will become 'Oxford Events' (full details are available on the Staff Gateway).
There will be an OxTalks freeze beginning on Friday 14th November. This means you will need to publish any of your known events to OxTalks by then as there will be no facility to publish or edit events in that fortnight. During the freeze, all events will be migrated to the new Oxford Events site. It will still be possible to view events on OxTalks during this time.
If you have any questions, please contact halo@digital.ox.ac.uk
The first FDA-approved gene therapy, Kymriah, was released to the public in August 2017 with a $475,000 price tag. With the emergence of personalized genetic medicine, we are entering a new era of profound inequality. This talk explores the stories of children and parents who signed up for the Kymriah clinical trial before it was approved—risking their lives and household finances in pursuit of a cancer cure. Issues of race and class played out at Penn Medicine, as researchers explored new horizons of hope with living cellular therapies.
